Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-14

Clinical Trial Update: Treatment of Melasma With Jessner's Solution vs. Trichloroacetic Acid [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Jessner's solution to Trichloroacetic acid for melasma has completed. The study was sponsored by Emory University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jessner's solution
  • Trichloroacetic acid (trichloroacetic acid)

Snippet

Sponsor: Emory University | Conditions: Melasma | Phase 4 | Status: COMPLETED